Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trialNalinie Joharatnam‐Hogan, R. Steele, Alistair Ring et al.|The Lancet. Gastroenterology & hepatology|2019Cited by 64